| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/20/2004 | US6723498 Chk1 and uses thereof |
| 04/20/2004 | US6723354 Methods and means for preventing or treating inflammation or pruritis |
| 04/20/2004 | US6723321 Modulation of lyase activity; obtain sample containing lyase, incubate with substrate and modulator, monitor adjustment in binding of substrate to lyase, adjustment in binding indicates modulator |
| 04/20/2004 | CA2223729C Universal primer sequence for multiplex dna amplification |
| 04/18/2004 | CA2427390A1 Methods of using a nod2/card15 haplotype to diagnose crohn's disease |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004032017A1 Liver cancer forecasting system for early diagnosis and control method thereof |
| 04/15/2004 | WO2004031912A2 Methods for estimating haplotype frequencies and disease associations with haplotypes and environmental variables |
| 04/15/2004 | WO2004031775A2 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | WO2004031774A2 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | WO2004031773A1 Fret protease assays for clostridial toxins |
| 04/15/2004 | WO2004031771A1 Method for detecting analytes |
| 04/15/2004 | WO2004031769A1 Interaction detecting method and bioassay device, and bioassay-use substrate |
| 04/15/2004 | WO2004031733A2 Methods of generating and screenign for porteases with altered specificity |
| 04/15/2004 | WO2004031729A2 Diagnostic for long term response of hbv carrier to 3tc therapy |
| 04/15/2004 | WO2004031728A2 Method and system for producing customized skin care formulations using genetic information |
| 04/15/2004 | WO2004031725A2 Ratios of collagen peptides, their uses and products |
| 04/15/2004 | WO2004031417A1 Method for estimating the risk of carcinoma development |
| 04/15/2004 | WO2004031416A1 Method and kit for quantitative and qualitative determination of human papillomavirus |
| 04/15/2004 | WO2004031415A2 Methods and compositions for rapid development of screening assays nuclear receptors |
| 04/15/2004 | WO2004031414A2 Method for diagnosing prostate cancer |
| 04/15/2004 | WO2004031413A2 Method for diagnosing non-small cell lung cancers |
| 04/15/2004 | WO2004031412A2 Method for diagnosing pancreatic cancer |
| 04/15/2004 | WO2004031411A2 Genes and polypeptides relating to human pancreatic cancers |
| 04/15/2004 | WO2004031410A2 Method for diagnosing testicular seminomas |
| 04/15/2004 | WO2004031409A2 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | WO2004031408A1 Oligonucleotides for genotyping thymidylate synthase gene |
| 04/15/2004 | WO2004031407A1 DETECTING THE RISK OF CARDIOVASCULAR DISEASES BY DETECTING MUTATIONS IN GENES, INCLUDING GENES ENCODING a2b-ADRENOCEPTOR AND APOLIPOPROTEIN B |
| 04/15/2004 | WO2004031406A2 Method for detecting single nucleotide polymorphisms on polydimensional microarrays |
| 04/15/2004 | WO2004031405A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | WO2004031404A1 Protein labelling with o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | WO2004031403A1 Method for detecting and counting micro-organisms in a sample |
| 04/15/2004 | WO2004031402A2 Methylation profile of cancer |
| 04/15/2004 | WO2004031398A2 Genetic diagnosis of depression |
| 04/15/2004 | WO2004031397A2 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value |
| 04/15/2004 | WO2004031392A1 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| 04/15/2004 | WO2004031381A1 Peptide capable of binding to nanographite structures |
| 04/15/2004 | WO2004031374A2 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 04/15/2004 | WO2004031366A2 Manufacturing method and readout system for biopolymer arrays |
| 04/15/2004 | WO2004031365A2 Sulfatases and methods of use thereof |
| 04/15/2004 | WO2004031360A2 Therapeutic aptamers having binding specificity to gp41 of hiv |
| 04/15/2004 | WO2004031355A2 Methods for identifying inhibitors of botulinum neurotoxins |
| 04/15/2004 | WO2004031354A2 Human sarcoma-associated antigens |
| 04/15/2004 | WO2004031351A2 Microarrays having multiple oligonucleotides in single array features |
| 04/15/2004 | WO2004031239A2 Metastasis inducing compounds |
| 04/15/2004 | WO2004031237A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | WO2004031233A2 Novel chemokine-like polypeptides |
| 04/15/2004 | WO2004031231A2 Genes and polypeptides relating to prostate cancers |
| 04/15/2004 | WO2004031216A1 Substrate for tafi (a) |
| 04/15/2004 | WO2004031208A2 Promoter sequences for corticotropin releasing factor binding protein and use thereof |
| 04/15/2004 | WO2004031142A2 Inhibition of metallo-beta-lactamase |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030699A1 Use of molecules which interact with the haptoglobin receptor ligand binding |
| 04/15/2004 | WO2004030689A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | WO2004030511A2 Prostate cancer biomarkers |
| 04/15/2004 | WO2004015134A3 Method of determining the cleavage activity of an endonuclease |
| 04/15/2004 | WO2004013349A3 Method for examining and evaluating virus enzymes in high throughput screening (hts) |
| 04/15/2004 | WO2004012757A3 Apolipoprotein l-i for the treatment or diagnosis of prypanosomaldiseases |
| 04/15/2004 | WO2004009847A3 Functional screening method involving protein translocation/redistribution |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2004003545A9 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 04/15/2004 | WO2004000875A3 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 04/15/2004 | WO2003104803A3 Method for mapping and eliminating t-cell epitopes |
| 04/15/2004 | WO2003104483A3 Methods and compositions for the identification of modulators of deoxyxylulose 5-phosphate synthase activity |
| 04/15/2004 | WO2003103704A3 L(2)44 dea, wunen-2, grapes, cg2221, cg1172, rutabaga, cg11940, facl involved in the regulation of energy homeostasis |
| 04/15/2004 | WO2003097794A3 Universal-tagged oligonucleotide primers and methods of use |
| 04/15/2004 | WO2003093505A3 Method for determining the presence of an unconventional transmissible agent responsible for transmissible subacute spongiform encephalopathy |
| 04/15/2004 | WO2003089606A3 Thermostable dna polymerases and methods of making same |
| 04/15/2004 | WO2003089457B1 Peptide inhibitors of protein kinase c ϝ for pain management |
| 04/15/2004 | WO2003088922A3 E7 regulation of p21cip1 through akt |
| 04/15/2004 | WO2003085134A3 Methods of diagnosing and treating colorectal cancer |
| 04/15/2004 | WO2003083490A3 Method for predicting antiphospholid syndrome |
| 04/15/2004 | WO2003078582B1 Integrated system for high throughput capture of genetic diversity |
| 04/15/2004 | WO2003078570A3 Multiple controls for molecular genetic analyses |
| 04/15/2004 | WO2003072827A8 Method for diagnosis and treatment of rheumatoid arthritis |
| 04/15/2004 | WO2003068151A3 Human antibodies for therapy against vaccinia or smallpox |
| 04/15/2004 | WO2003054212A8 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 04/15/2004 | WO2003050250B1 Chondrocyte precursors derived from human embryonic stem cells |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 04/15/2004 | WO2003044215A3 Methods for evaluating drug-resistance gene expression in the cancer patient |
| 04/15/2004 | WO2003043580A3 Methods for identifying and validating potential drug targets |
| 04/15/2004 | WO2003040386A3 Reaction chambers containing complex stable reagent formulations and test kit for detection and isolation of pathogenic microbial nucleic acids |
| 04/15/2004 | WO2003012062A9 Animal model with disrupted fgf14 gene |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2003002756A9 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002097131A9 Method for detecting defoliating and non-defoliating pathotypes of verticillium dahliae in plants |
| 04/15/2004 | WO2002090993A3 Functional protein expression for rapid cell-free phenotyping |
| 04/15/2004 | WO2002081740A3 Supported double-layer structure for displaying a nucleic acid associated with a protein |
| 04/15/2004 | WO2002081703A9 Mitogenic oxygenase regulators |
| 04/15/2004 | WO2002064763A8 Novel human poly(a)polymerase gamma (pap gamma) |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002055721A3 Modular transfection systems based on nucleoprotein filaments |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2002048403B1 Multiplexed protein expression and activity assay |
| 04/15/2004 | WO2002034953A3 Detection and quantification of human herpes viruses |
| 04/15/2004 | WO2002016553B1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 04/15/2004 | WO2001092479A8 Method to determine the differentiation potential of a target cell |
| 04/15/2004 | WO2001070955A8 Identification of essential genes in prokaryotes |